Advertisement

Topics

DRUG DISCOVERT TODAY Company Profile

23:45 EST 16th December 2018 | BioPortfolio

Nil

Contact

Email: ddt@drugdiscoverytoday.com.


News Articles [1160 Associated News Articles listed on BioPortfolio]

STAT Plus: Pharmalittle: Trump to give speech today on drug pricing; FDA approves a novel, but pricey flu drug

The Food and Drug Administration approved the first new flu drug with a novel mechanism of action in nearly 20 years.

Drug Discovery Today: highlighted review. ‘Metabolite-likeness’ as a criterion in the design and selection of pharmaceutical drug libraries

This highlighted review from Drug Discovery Today by Dobson, Patel and Kell outlines how "metabolite-likeness" in an analogous manner to "drug-likeness" and "lead-likeness" can be used to improve the ...

The Current issue of “The view from here” is concerned with Drug Delivery.

The topic of this month’s newsletter from Drug Discovery Today is “Drug Delivery”.

The Current issue of “The view from here” is concerned with Drug Delivery

The topic of this month’s newsletter from Drug Discovery Today is “Drug Delivery”.

Drug Discovery Today Citation Classic: The growing impact of click chemistry on drug discovery.

Welcome to the first article in Drug Discovery Today Citation Classics. I would say that it is very hard to predict what articles will make citation classic articles, but I suppose that having a Nobel...

The Case for Approving a Drug Never to Be Used (We Hope)

(MedPage Today) -- Just such a drug is now under FDA review

Two-Drug HIV Combo Hits Mark

(MedPage Today) -- Matches efficacy of three-drug approach

FDA Approves 6th Drug for HAE

(MedPage Today) -- Also the 6th to receive orphan drug status for the rare condition

PubMed Articles [2714 Associated PubMed Articles listed on BioPortfolio]

Drug development and therapeutic solutions in the digital age.

The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions.

As the name suggests, drug repurposing is a strategy to identify new therapeutic uses for marketed drugs, discontinued and/or shelved drugs, and drug candidates currently in clinical development. Alth...

Toward improving drug delivery research in Egypt: Cancer Nanotechnology Research Laboratory as a role model.

Renovation as innovation: is repurposing the future of drug discovery research?

Artificial intelligence in drug development: present status and future prospects.

Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems. Remarkable improvements in computational power...

Clinical Trials [2688 Associated Clinical Trials listed on BioPortfolio]

TODAY! A Mobile App Study

The aim of this study is to conduct a small randomized controlled trial (RCT) for a 10-week mobile phone intervention using principles of Cognitive Behavior Therapy to target general and m...

Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) has sponsored a consortium of investigators to conduct a clinical tr...

Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens

The joint status (knees, ankles) of patients suffering from severe Hemophilia A (too little blood clotting factor VIII in blood) is evaluated in a single magnetic resonance imaging session...

Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up

The objective of the study is to evaluate the process of early re-endothelialization of the Coroflex® ISAR Drug-eluting stent compared with the Ultimaster® Drug-eluting stent

DDI Effectiveness and Clinical Awareness

The DECART study will determine if primary care physicians, including internists and family physicians, are able to identify and address drug-drug interactions among simulated patients and...

Companies [1996 Associated Companies listed on BioPortfolio]

DRUG DISCOVERT TODAY

Nil

Lil' Drug Store Products, Inc.

Lil' Drug Store Convenience Division provides a wide variety of products and merchandising vehicles to convenience stores, club stores, and other classes of trade nationwide. Retailers can find everyt...

Verseon

Verseon is a technology-based pharmaceutical company that employs its proprietary computational drug discovery platform to develop novel therapeutics for today’s challenging ...

National Association of Chain Drug Stores

Founded in 1933 by six chain executives, the National Association of Chain Drug Stores worked to provide the chain drug industry with a unified voice necessary for growth and success. More than 70 yea...

Epic Therapeutics Incorporated

Epic Therapeutics, Inc. has developed a proprietary, protein-matrix drug delivery technology, ProMaxx®, that is produced entirely in water and is substantially more versatile and cost-effective at so...

More Information about "DRUG DISCOVERT TODAY" on BioPortfolio

We have published hundreds of DRUG DISCOVERT TODAY news stories on BioPortfolio along with dozens of DRUG DISCOVERT TODAY Clinical Trials and PubMed Articles about DRUG DISCOVERT TODAY for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DRUG DISCOVERT TODAY Companies in our database. You can also find out about relevant DRUG DISCOVERT TODAY Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record